Cvs Pharmacy #00047 Durable Medical Equipment & Medical Supplies Location: 12024 Lamey Bridge Rd, Diberville, Mississippi 39540 Phone: (228) 396-2858 |
Cvs Pharmacy #17532 Durable Medical Equipment & Medical Supplies Location: 3867 Promenade Pkwy, Diberville, Mississippi 39540 Phone: (228) 233-3302 |
Winn-dixie Pharmacy #1513 Medicare Supplier Location: 10551 Diberville Blvd, Diberville, Mississippi 39540 Phone: (228) 392-3560 |
Walmart Pharmacy 10-2715 Durable Medical Equipment & Medical Supplies Location: 3615 Sangani Blvd, Diberville, Mississippi 39540 Phone: (228) 396-4778 |
Walgreens #10909 Durable Medical Equipment & Medical Supplies Location: 12007 Lamey Bridge Rd, Diberville, Mississippi 39540 Phone: (228) 392-2388 |
Saad Medical Equipment -d'iberville Durable Medical Equipment & Medical Supplies Location: 10598 Diberville Blvd, Diberville, Mississippi 39540 Phone: (228) 432-5622 |
Walgreens #17035 Durable Medical Equipment & Medical Supplies Location: 4031 Popps Ferry Rd, Diberville, Mississippi 39540 Phone: (228) 392-7310 |
Coast Eyes Pllc Medicare Supplier Location: 4233 W Gay Rd, Diberville, Mississippi 39540 Phone: (228) 392-8141 |
News Archive
When we think of pain we generally think of something that is related to our body. But there is a devastating form of pain that is not frequently acknowledged and is a topic of a paper by Eliana Tossani (University of Bologna) in the current issue of Psychotherapy and Psychosomatics.
Isis Pharmaceuticals, Inc. announced today positive data from a Phase 2 study of ISIS-GCGRRx in patients with type 2 diabetes uncontrolled on stable metformin therapy.
New research by scientists at The University of Texas Health Science Center at Houston (UTHealth) and The University of Texas M. D. Anderson Cancer Center could make it easier for patients to use a family of promising experimental cancer therapeutics known as small interfering RNA (siRNA).
A new online open-access database has been developed by scientists to allow the clinical responses of more than 5 million patients to all FDA-approved drugs to be used to identify unexpected clinical harm, benefits and alternative treatment choices for individual patients, according to a study appearing July 8 in Nature Biotechnology.
Women and men experience a similar prevalence of adverse drug reactions in the treatment of coronary artery disease; however, women are significantly less likely than their male counterparts to be treated with statins, aspirin, and beta-blockers according to a new study by researchers at Rush University Medical Center.
› Verified 6 days ago